Back to Search

WILLIAM MATTHAI, MD

MD

Cardiovascular Disease Physician

NPI: 1699702597Individual

Specialties, Licenses & Credentials

Cardiovascular Disease PhysicianPrimary

Internal Medicine — Cardiovascular Disease

Code: 207RC0000X

25MA05637200(NJ)MD034664E(PA)
Interventional Cardiology Physician

Internal Medicine — Interventional Cardiology

Code: 207RI0011X

MD034664E(PA)
Nuclear Cardiology Physician

Nuclear Medicine — Nuclear Cardiology

Code: 207UN0901X

MD034664E(PA)

Research & Publications (20)

Safety and efficacy of argatroban in patients with heparin-induced thrombocytopenia.
PMID 16537053·Curr Hematol Rep·2006
6-review
Treatment of heparin-induced thrombocytopenia in cardiovascular patients.
PMID 16448321·Expert Opin Pharmacother·2006
6-review
Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia.
PMID 15907526·Thromb Res·2005
3-trial
Thrombocytopenia in cardiovascular patients: diagnosis and management.
PMID 15706030·Chest·2005
6-review
Towards a diagnosis of heparin-induced thrombocytopenia after cardiopulmonary bypass.
PMID 15550014·J Thromb Haemost·2004
8-other
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants.
PMID 19198609·Nat Genet·2009
8-other
Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts.
PMID 18561143·Catheter Cardiovasc Interv·2008
4-observational
Revascularization in severe left ventricular dysfunction: outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting.
PMID 17585381·Catheter Cardiovasc Interv·2007
4-observational
Electron-beam computerized tomography correlates with coronary angiogram in chronic kidney disease patients.
PMID 17389785·Am J Nephrol·2007
3-trial
Improved survival with drug-eluting stent implantation in comparison with bare metal stent in patients with severe left ventricular dysfunction.
PMID 16892436·Catheter Cardiovasc Interv·2006
4-observational
Argatroban anticoagulation in conjunction with glycoprotein IIb/IIIa inhibition in patients undergoing percutaneous coronary intervention: an open-label, nonrandomized pilot study.
PMID 15744551·J Thromb Thrombolysis·2004
4-observational
One-year clinical outcomes of protected and unprotected left main coronary artery stenting.
PMID 12927190·Eur Heart J·2003
8-other
Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention.
PMID 12871688·Eur Heart J·2003
8-other
Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
PMID 12357516·Catheter Cardiovasc Interv·2002
8-other
Evaluating the etiology of mechanical valve obstruction: use of clinical parameters, fluoroscopy, and echocardiography.
PMID 11948898·Catheter Cardiovasc Interv·2002
5-case
Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.
PMID 11294800·Circulation·2001
3-trial
Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention.
PMID 11287711·J Invasive Cardiol·2001
3-trial
Predictors of clinical outcome following percutaneous intervention for in-stent restenosis.
PMID 10856387·Am J Cardiol·2000
8-other
Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial.
PMID 10801758·Circulation·2000
3-trial
Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: "NICE guys finish first".
PMID 10731289·J Invasive Cardiol·2000
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
51 NORTH 39TH STREET, 4 PHI
PHILADELPHIA, PA 19104

Location

Practice Location

51 NORTH 39TH STREET, PHILADELPHIA, PA
(215) 662-9189

Quick Facts

NPI
1699702597
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
4
Locations
1
Publications
20

Are you this provider?

Claim Your Profile